Pfizer/BioNTech Vaccine Protects Children Against Rare COVID-19 Complication: CDC

January 10, 2022

(Medscape) – Two doses of the Pfizer Inc and BioNTech COVID-19 vaccine are highly protective against a rare but often serious condition in children that causes organ inflammation weeks after COVID-19 infections, a U.S. Centers for Disease Control and Prevention report said on Friday. The vaccine was estimated to be 91% effective in preventing Multisystem Inflammatory Syndrome in Children (MIS-C) in 12- to 18-year-olds, the study said. (Read More)